scientific program • symposia - American Society for Reproductive ...

More documents

Recommendations

Info

Disclosure Statements/Conflict of Interest Policy Honoraria The following speakers may receive honoraria and/or discounted or free registration: • Plenary Speakers • Postgraduate Course Faculty • Symposia Speakers • Interactive Session Speakers The following speakers do not receive honoraria: • Roundtable Presenters • Abstract Presenters • Video Presenters Disclosure Statements Postgraduate Faculty, Symposia Speakers, Plenary Lecturers, Abstract Authors, Abstract Graders, Roundtable Presenters, Video Presenters, and Interactive Speakers are required to disclose commercial relationships or other activities that might be perceived as potential conflicts of interest. Postgraduate course faculty disclosures wiill be listed in the course syllabi. Symposium speakers’ disclosures will be presented in handout materials, as well as on slides. Disclosures from speakers in the Plenary Sessions, Interactive Sessions, Roundtables, Videos and Symposia will be published in the Final Program. Abstract authors’ disclosures will be published in the 2011 Program Supplement. Each presenter should reveal his/her disclosure information during his/her presentation, preferably with the visual aid of a slide. Roundtable presenters should provide a copy of their disclosure forms to the participants at their table. AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE 2011 Conflict of Interest Policy for Invited Speakers As a provider of continuing medical education (CME) accredited by the Accreditation Council for Continuing Medical Education (ACCME), the American Society for Reproductive Medicine must ensure balance, independence, objectivity and scientific rigor in all its educational activities. All presenters must disclose to the learners any commercial or financial interests and/or other relationships with manufacturers of pharmaceuticals, laboratory supplies and/or medical devices. All relationships, whether or not they directly apply to this CME event, must be disclosed. All non-FDA approved uses of products must be clearly identified. Disclosures may be made in the form of a slide, printed material, or oral statement. The intent of this disclosure is not to prevent a speaker with a commercial or financial interest from making a presentation. The intent is to assist ASRM in resolving conflicts of interest and to provide learners with information on which they can make their own judgments regarding any bias. Although ASRM reviews and resolves potential conflicts of interest, it remains for the audience to determine whether the speaker’s interests or relationships may influence the presentation with regard to exposition or conclusion. Disclosures will be revealed to the learners. For postgraduate courses, disclosure information will be provided in the syllabus. For other activities, where no syllabus or other similar printed material is available, disclosures must be made verbally to the audience by the speakers, preferably with the visual aid of a slide. For those situations where there is no potential for conflict of interest, the portion of the form that so states should be completed. In those situations where a speaker does not complete a form or refuses to complete a form, the individual is ineligible to participate as a speaker in the CME activity. Speakers should also reveal to the audience any “off label” uses (not approved by the FDA) of any drugs or products discussed. Abstract authors’ disclosures are listed in the 2011 Program Supplement. Speakers in the Symposia and Interactive, Video, Roundtable and Abstract Sessions have also complied with ASRM policies and their disclosures are on file in the ASRM office. The speaker should reveal this information during his/her presentation, preferably with the visual aid of a slide. 13
Look for this symbol as an indicator of an activity using our Audience Response System. When you see it, please be sure to bring your cell phone with you. Audience Response System Instructions OPTION 1 Text message your response with your cell phone “DIAL” OPTION 2 Web response with your Smartphone’s mobile broadband Type answer code d Sessions wi with Audience Response p will allow you to respond two ways 11111 http://pollev.com Web responses 11111 14 “TEXT” answer code 11111 22222 33333 Note: Standard text messaging rates and/or surcharges may apply. Enter URL – web address dd 11111 22222 Click “Submit” Submit 33333 Note: Standard data rates and/or surcharges may apply.
Page 2: Merck Helping you help families gro
Page 6 and 7: SHOPPING When it comes to distincti
Page 8 and 9: WELCOME Roger A. Lobo, M.D. ASRM Pr
Page 10 and 11: SCIENTIFIC PROGRAM & ABSTRACT REVIE
Page 12 and 13: ASRM ANNUAL MEETING POLICIES AND DI
Page 14 and 15: CONTINUING EDUCATION (CME/CE) INFOR
Page 18 and 19: REGISTRATION AND OTHER IMPORTANT ME
Page 20 and 21: Product Theater We encourage you to
Page 22 and 23: ORANGE COUNTY CONVENTION CENTER FLO
Page 24 and 25: ORANGE COUNTY CONVENTION CENTER FLO
Page 26 and 27: PEABODY ORLANDO HOTEL FLOORPLANS LO
Page 28 and 29: Sign up for Automatic Dues Renewal
Page 30 and 31: SATURDAY, OCTOBER 15 2011 ASRM ANNU
Page 32 and 33: 2011 ASRM ANNUAL MEETING • DAILY
Page 38 and 39: CONTRACEPTION DAY TUESDAY, OCTOBER
Page 42 and 43: American Society for Reproductive M
Page 44 and 45: New Member/First Time Attendee Rece
Page 46 and 47: POSTGRADUATE COURSE LOCATIONS COURS
Page 48 and 49: 44 TH ANNUAL POSTGRADUATE PROGRAM C
Page 50 and 51: 44 TH ANNUAL POSTGRADUATE PROGRAM D
Page 52 and 53: 44 TH ANNUAL POSTGRADUATE PROGRAM L
Page 56 and 57: 44 TH ANNUAL POSTGRADUATE PROGRAM m
Page 58 and 59: 44 TH ANNUAL POSTGRADUATE PROGRAM N
Page 62 and 63: NOTES _____________________________
Page 64 and 65: SCIENTIFIC PROGRAM • PLENARY SESS
Page 66 and 67:
SCIENTIFIC PROGRAM • PLENARY SESS
Page 68 and 69:
SCIENTIFIC PROGRAM • PLENARY SESS
Page 70 and 71:
ASRM Career Center (Position Placem
Page 72 and 73:
SCIENTIFIC PROGRAM • SYMPOSIA Mon
Page 74 and 75:
Page 76 and 77:
Page 78 and 79:
Page 80 and 81:
SCIENTIFIC PROGRAM • SYMPOSIA Tue
Page 82 and 83:
SCIENTIFIC PROGRAM • SYMPOSIA Tue
Page 84 and 85:
SCIENTIFIC PROGRAM • SYMPOSIA Wed
Page 86 and 87:
BETTER PCOS TREATMENT? OVARIAN STIM
Page 88 and 89:
MAKING AN IMPACT Alicia Armstrong,
Page 90 and 91:
NOTES _____________________________
Page 92 and 93:
SCIENTIFIC PROGRAM • INTERACTIVE
Page 94 and 95:
Page 96 and 97:
Page 98 and 99:
Page 100 and 101:
Page 102 and 103:
Page 104 and 105:
2011 VIDEO PROGRAM Tuesday, October
Page 106 and 107:
seconds and time-lapse digital reco
Page 108 and 109:
VIDEO PROGRAM Tuesday, October 18,
Page 110 and 111:
MATERIALS AND METHODS: Conservative
Page 112 and 113:
Best Endoscopic Surgical Videos of
Page 114 and 115:
ORAL ABSTRACTS Monday, October 17,
Page 116 and 117:
O-20 5:15 PM URINARY BISPHENOL A AN
Page 118 and 119:
SEXUALITY ROOM 240 A/B Moderators:
Page 120 and 121:
PROCEDURES AND TECHNIQUES-CLINICAL:
Page 122 and 123:
O-108 5:45 PM GUM CHEWING STIMULATE
Page 124 and 125:
O-130 5:30 PM EXPERIENCE WITH GAY M
Page 126 and 127:
FERTILITY PRESERVATION ROOM 330 E M
Page 128 and 129:
O-186 6:00 PM THE ROLE OF FSH RECEP
Page 130 and 131:
REPRODUCTIVE ENDOCRINOLOGY: CLINICA
Page 132 and 133:
O-229 12:15 PM N-GLYCOLYLNEURAMINIC
Page 134 and 135:
FERTILITY PRESERVATION ROOM 330 E M
Page 136 and 137:
PROCEDURES AND TECHNIQUES-LABORATOR
Page 138 and 139:
O-316 5:30 PM UTERINE REMNANTS AND
Page 140 and 141:
O-341 5:30 PM BLASTOCYST QUALITY IN
Page 142 and 143:
PRIZE PAPERS, IN-TRAINING & PRIZE V
Page 144 and 145:
PRIZE PAPERS, IN-TRAINING, AND PRIZ
Page 146 and 147:
NOTES _____________________________
Page 148 and 149:
Join Us for Our Annual Meeting Post
Page 150 and 151:
137 437 138 438 139 439 140 440 141
Page 152 and 153:
P-10 ONE-YEAR OF FOLLOW-UP OF LEVON
Page 154 and 155:
P-46 GnRH ALTERS PITUITARY ADIPONEC
Page 156 and 157:
ENDOMETRIOSIS P-82 microRNA 135a EX
Page 158 and 159:
P-119 ENDOMETRIAL PATTERN CHANGE FR
Page 160 and 161:
P-158 PREVALENCE OF HYPERPROLACTINE
Page 162 and 163:
P-197 ABNORMAL SPERM COUNT, WHO MOR
Page 164 and 165:
P-234 LIVE BIRTH RATE AFTER SINGLE
Page 166 and 167:
ART - OUTCOME PREDICTORS, CLINICAL
Page 168 and 169:
POSTER PRESENTATIONS Wednesday, Oct
Page 170 and 171:
P-324 SUSHI DOMAIN CONTAINING 3 (SU
Page 172 and 173:
P-366 SPERM RECOVERY AFTER CRYOPRES
Page 174 and 175:
P-406 CHROMOSOMAL MOSAICISM IN DAY-
Page 176 and 177:
P-446 DEHYDROEPIANDROSTERONE SUPPLE
Page 178 and 179:
P-486 METABOLOMIC PROFILE OF EMBRYO
Page 180 and 181:
P-523 MINIMAL VS. CONVENTIONAL OVAR
Page 182 and 183:
P-562 USE OF ULTRASOUND-GUIDED EMBR
Page 184 and 185:
MEET AND GREET THE ASRM PRESIDENT A
Page 186 and 187:
ROUNDTABLE LUNCHEONS Tuesday, Octob
Page 188 and 189:
FUTURE ASRM ANNUAL MEETINGS October
Page 190 and 191:
EXHIBITS ORANGE COUNTY CONVENTION C
Page 192 and 193:
2011 EXHIBIT HALL FLOORPLAN • ORA
Page 194 and 195:
Roche Diagnostics 2037 Rocket Medic
Page 196 and 197:
SPOUSE/GUEST HOSPITALITY ROOM SATUR
Page 198 and 199:
ASRM ADMINISTRATIVE STAFF 1209 Mont
Page 200 and 201:
PARTICIPANT AND SPOUSE/PARTNER DISC
Page 202 and 203:
PARTICIPANT AND SPOUSE/PARTNER DISC
Page 204 and 205:
187
Page 206 and 207:
ABSTRACTS TOPIC INDEX Female Reprod
Page 209 and 210:
Aasted, H., O-61, P-511 Abanto, E.,
Page 211 and 212:
Ben Yosef, D., P-398 Benadiva, C. A
Page 213 and 214:
Chazenbalk, G., P-19 Cheang, K. I.,
Page 215 and 216:
Doshi, A., P-559 Dott. Benedetti, S
Page 217 and 218:
Gnocchi, D. C., P-166, P-272 Go, K.
Page 219 and 220:
Hu, J. C. Y., O-82, P-208, P-440, P
Page 221 and 222:
Kim, S., P-298, P-298 Kim, S. G., P
Page 223 and 224:
Loh, S. F., P-321 Lomax, J., P-335
Page 225 and 226:
Monzo, C., P-347 Moodie, G. R., P-4
Page 227 and 228:
Pavone, M. E., O-263, O-328, P-96,
Page 229 and 230:
Sagle, M., P-561 Sahin, O., P-345 S
Page 231 and 232:
Souza, G. M., O-295 Spaine, D., P-3
Page 233 and 234:
Vasconcelos, A., O-38 Vause, T. C.
Page 235:
Zhou, S. C., P-210, P-215 Zhou, Y.,
Page 238 and 239:
PROGRAM PARTICIPANTS - NON-ORAL/POS
Page 240 and 241:
PROGRAM PARTICIPANTS - NON-ORAL/POS
Page 242 and 243:
NOTES _____________________________
Page 244 and 245:
ASRM would like to thank those who
Page 246 and 247:
News and Education • Access to cu
Page 248:
At Your Fingertips Professional tec
Page 252 and 253:
The Leaders in Single Gene PGD and
Page 254:
Supported by EMD Serono, Abbott Lab
show all

scientific program • symposia - American Society for Reproductive ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?